Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy Meeting Abstract

  

Authors:	Saab, K.; Mooradian, M.; Wang, D. Y.; Chon, J.; Xia, C. Y.; Bialczak, A.; Abbate, K.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; Shoushtari, A. N.
Abstract Title:	Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Start Page:	499s
Language:	English
ACCESSION:	WOS:000442916003315
DOI:	10.1200/JCO.2018.36.15_suppl.9540
PROVIDER:	wos
Notes:	Meeting Abstract: 9540 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169613